The effects of recombinant human active protein C on inflammation and NOS in sepsis

L. Sepit, A. Sakar, S. Vatansever, S. Cilakar, A. Yorgancioglu (Manisa, Turkey)

Source: Annual Congress 2005 - Mechanisms and markers of ARDS and sepsis
Session: Mechanisms and markers of ARDS and sepsis
Session type: Poster Discussion
Number: 1425

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Sepit, A. Sakar, S. Vatansever, S. Cilakar, A. Yorgancioglu (Manisa, Turkey). The effects of recombinant human active protein C on inflammation and NOS in sepsis. Eur Respir J 2005; 26: Suppl. 49, 1425

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human protein C concentrate administration reduces inflammation and apoptosis in lung after experimental sepsis
Source: Eur Respir J 2005; 26: Suppl. 49, 461s
Year: 2005

Visualization of apoptosis-related proteins in lung treated with recombinant human active protein C in sepsis model
Source: Eur Respir J 2005; 26: Suppl. 49, 221s
Year: 2005

Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


N-acetyl cysteine inhibits IL-17-induced IL-8 production from human airway smooth muscle cells - a possible role for anti-oxidant treatment in chronic lung rejection?
Source: Eur Respir J 2003; 22: Suppl. 45, 202s
Year: 2003

Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006

Activated protein C protection in endotoxin-induced lung injury is mediated by lung matrix metalloproteinases activity
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Effects of iNOS inhibition on nNOS expression in inflammatory and bronchial epithelial cells in guinea pigs with chronic lung inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 344s
Year: 2005

Effects of pendrin inhibitor (PDI_C01) in vitro, and in vivo models of lipopolysaccharide-induced airway inflammation.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019


A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013

The role of inducible NO synthase (iNOS) in a cell model of steroid resistance in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008


Inhibition of elastinolytic activity in induced sputum from COPD patients and healthy controls by recombinant alpha 1-antitrypsin (rAAT) and a fusion protein, TAPI
Source: Eur Respir J 2004; 24: Suppl. 48, 471s
Year: 2004

The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury
Source: Eur Respir J 2008; 32: 862-870
Year: 2008



Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005


Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Enhanced lung fibrosis in protein C inhibitor transgenic mice
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004

Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Source: Eur Respir J 2003; 21: 394-400
Year: 2003



High proteasome activity and absence of NF-kB activation in cystic fibrosis cell culture and CF KO mouse models in response to oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 403s
Year: 2005